Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the health-check domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /dom76025/wp-includes/functions.php on line 6121
June 13, 2024 - Page 5 of 5 - The Dermatology Digest
Subscribe
Search

Day: June 13, 2024

FDA Approves Tralokinumab Autoinjector Pen for Adults With Moderate to Severe AD

The U.S. Food and Drug Administration (FDA) has given its nod to tralokinumab-ldrm (Adbry, Leo Pharma) 300mg single-dose autoinjector for adults with moderate to severe atopic dermatitis (AD). Tralokinumab-ldrmis is a high-affinity fully human monoclonal antibody developed to bind to and inhibit the interleukin (IL)-13 cytokine. The new autoinjector is another option for adult patients […]